Thursday Sep 11
Expanded Rutgers career fair offers more opportunitiesExpanded...
Expanded Rutgers career fair offers more opportunities Rutgers Career Services' Career & Intership Mega Fair has expanded to two days with a record 300 employers. Check out this story on mycentraljersey.com: http://mycj.co/1tDnojO Rutgers students and alumni recommended that their peers attend the university's expanded Career & Internship Mega Fair, which continues Friday on the Busch Campus.
Wed Sep 10, 2014
Johnson & Johnson's Management Presents at 2014 Morgan Stanley Health Care Conference
Good morning. It's a, sorry. So find your seats here. It's our pleasure to have this year this morning management team members from Johnson & Johnson, specifically the Chief Financial Officer, Dominic Caruso; so Stan Panasewicz, Senior Director of Investor Relations, obviously, you maybe know Stan.
A House of Cards for Pelvic Mesh?
A House of Cards: How consecutive multi-million dollar verdicts spell the beginning of the end for the pelvic mesh industry Last Friday, a West Virginia jury awarded $3.27 million to an Illinois woman in her case against industry giant Johnson & Johnson over her pelvic mesh implant, a controversial medical device that allegedly resulted in permanent nerve damage, chronic pain, and caused the former athlete trouble with walking, among other symptoms.
Wed Sep 03, 2014
Investor's Business Daily
Sharper Focus Pays Dividends At Johnson & Johnson
Judging by its Q2 earnings report, the strategy seems to be working. In July, the company and Dow industrials component reported strong second-quarter earnings.
Google is Ireland's No 1 exporter
Google Ireland is Ireland's top exporter with Microsoft coming in at No 2, according to the Top 250 Exporters in Ireland and Northern Ireland from the Irish Exporters Association and Investec.
Johnson & Johnson Facing New Lawsuits On Pinnacle Hips
Johnson & Johnson is facing a new round of lawsuits over its DePuy unit's Pinnacle line of metal-on-metal hip implants blamed for poisoning patients.
Tue Sep 02, 2014
J&J's Pinnacle Hips Face First Trial on Poisoned Patients
Johnson & Johnson , which set aside $2.5 billion last year to resolve claims that 8,000 of its artificial hips were defective, faces a new round of lawsuits over another line of hip implants blamed for poisoning patients.
The Columbus Dispatch
IBM's Watson moves from - Jeopardy!' to analyzing scientific research
Scott Spangler, principal data scientist for IBM Watson Innovations, demonstrates how its cognitive technology can display connections in scientific literature and drug information.
Mon Sep 01, 2014
Mendham Resident Pursues Lifelong Dream as Suspense/Thriller Novelist
In the neighboring town of Mendham, resident Bill Powers went from leading groups of scientists in the United States, Europe, and Asia, to pursuing his passion of being a fictional author.
Thu Aug 28, 2014
Johnson & Johnson to seek buyer for medical device maker unit -WSJ
Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
Salt Lake Tribune
IBM's Watson goes from Jeopardy! to J&J scientist
New York a IBM wants you to know that its Watson technology can do more than win "Jeopardy!": It can now help accelerate scientific research and discoveries.
Tue Aug 26, 2014
ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.
ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Mon Aug 25, 2014
Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs
Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.
Mon Aug 18, 2014
The Motley Fool
3 Reasons Johnson & Johnson Stock Could Rise
For the quarter, Johnson & Johnson delivered impressive revenue growth of 9.1% year-over-year.